Table 1:

Statistical table

FigureDescriptionData StructureHOVType of test95% CI for WT95% CI for Cntnap2−/−95% CI for Shank3+/Δ
1BDCX in the dorsal hippocampusNormalYesOne-way ANOVA14,077–17,7809,654–17,35211,360–18,927
1DDCX in the ventral hippocampusNormalYesOne-way ANOVA9,513–17,4964,572–11,0256,619–9,370
2CrGCs and hGCs in the dorsal hippocampusNormalYesOne-way ANOVA8,381–10,624 (rGCs)
15,576–17,671 (hGCs)		8,709–10,961 (rGCs)
14,914–16,793 (hGCs)		7,668–11,762 (rGCs)
15,604–19,204 (hGCs)
2FrGCs and hGCs in the ventral hippocampusNormalYesOne-way ANOVA6,766–10,273 (rGCs)
16,066–19,354 (hGCs)		3,469–7,123
(rGCs)
18,018–20,874 (hGCs)		4,636–6,844
(rGCs)
17,658–21,043 (hGCs)
N/ArGCs and DCX cells in the hippocampusNormalYesOne-way ANOVA0.51–0.71
(dorsal)
0.47–0.82 (ventral)		0.59–0.89
(dorsal)
0.57–0.98 (ventral)		0.51–0.82
(dorsal)
0.49–0.89 (ventral)
3BGFAP density in the dorsal hippocampusNon-normal (MOL)Normal (RAD)No (MOL)Yes (RAD)Kruskal–Wallis (MOLOne-way ANOVA (RAD)30,863–35,020 (MOL)27,638–32,713 (RAD)31,880–35,640 (MOL)27,138–31,130 (RAD)26,868–39,752 (MOL)27,501–32,706 (RAD)
3CGFAP domain area in the dorsal hippocampusNormalYesOne-way ANOVA795–1,063 (MOL)912–1,168 (RAD)756–935 (MOL)869–1,202 (RAD)731–870 (MOL)630–899 (RAD)
3EGFAP density in the ventral hippocampusNormalYesOne-way ANOVA33,738–37,726 (MOL)25,884–30,244 (RAD)36,894–40,994 (MOL)24,924–29,812 (RAD)30,727–39,249 (MOL)23,393–30,019 (RAD)
3FGFAP domain area in the ventral hippocampusNormalYesOne-way ANOVA749–911 (MOL)846–1,154 (RAD)669–860 (MOL)825–1,346 (RAD)635–860 (MOL)905–1,185 (RAD)
4BS100 density in the dorsal hippocampusNormalYesOne-way ANOVA17,245–21,751 (MOL)15,107–18,016 (RAD)14,940–17,997 (MOL)12,518–15,539 (RAD)12,911–21,489 (MOL)11,923–18,519 (RAD)
4CS100 morphology in the dorsal hippocampusNormalYesOne-way ANOVA51–64 (MOL)48–60 (RAD)51–65 (MOL)51–60 (RAD)44–63 (MOL)47–63 (RAD)
4ES100 density in the ventral hippocampusNormalYesOne-way ANOVA19,035–25,859 (MOL)13,518–17,458 (RAD)14,146–19,274 (MOL)11,222–13,369 (RAD)15,336–23,375 (MOL)11,410–16,797 (RAD)
4FS100 morphology in the ventral hippocampusNormalYesOne-way ANOVA47–59 (MOL)55–64 (RAD)48–61 (MOL)58–64 (RAD)42–57 (MOL)53–65 (RAD)
5BIba1 density in the dorsal hippocampusNormalYesOne-way ANOVA8,089–10,437 (MOL)8,091–9,830 (RAD)8,800–10,325 (MOL)8,378–9,594 (RAD)8,742–10,086 (MOL)8,160–9,113 (RAD)
5CIba1 cell body area in the dorsal hippocampusNormalYesOne-way ANOVA44–47 (MOL)41–43 (SGZ)41–45 (RAD)44–47 (MOL)42–44 (SGZ)42–45 (RAD)43–48 (MOL)41–45 (SGZ)42–46 (RAD)
N/AIba1 processes in the dorsal hippocampusNormalYesOne-way ANOVA5.38–6.49 (MOL)4.58–5.40 (SGZ)5.58–7.46 (RAD)5.96–6.82 (MOL)5.11–5.78 (SGZ)5.05–7.37 (RAD)5.56–6.50 (MOL)5.16–6.36 (SGZ)6.53–7.87 (RAD)
5EIba1 density in the ventral hippocampusNormalYesOne-way ANOVA8,799–11,297 (MOL)7,208–8,912 (RAD)7,995–9,825 (MOL)7,500–9,681 (RAD)8,597–10,955 (MOL)7,279–8,814 (RAD)
5FIba1 cell body area in the ventral hippocampusNormal (MOL, SGZ)Non-normal (RAD)Yes (MOL, SGZ)No (RAD)One-way ANOVA (MOL, SGZ)Kruskal–Wallis (RAD)43–45 (MOL)40–46 (SGZ)40–48 (RAD)43–46 (MOL)39–45 (SGZ)40–46(RAD)43–46 (MOL)43–47 (SGZ)43–46 (RAD)
N/AIba1 processes in the ventral hippocampusNormalYesOne-way ANOVA5.69–7.19 (MOL)4.58–5.78 (SGZ)5.37–6.95 (RAD)6.68–7.78 (MOL)4.83–5.83 (SGZ)5.34–7.26 (RAD)5.32–7.05 (MOL)4.62–5.44 (SGZ)5.88–7.66 (RAD)
6BCD68 percent area in the dorsal hippocampusNormalYesOne-way ANOVA25–52 (MOL)30–60 (SGZ)44–71 (RAD)37–64 (MOL)23–51 (SGZ)46–73 (RAD)36–60 (MOL)29–70 (SGZ)42–76 (RAD)
6DCD68 percent area in the ventral hippocampusNormal (MOL, SGZ)Non-normal (RAD)Yes (MOL, SGZ)No (RAD)One-way ANOVA (MOL, SGZ)Kruskal–Wallis (RAD)34–57 (MOL)35–65 (SGZ)43–68 (RAD)33–63 (MOL)30–54 (SGZ)70–75 (RAD)36–60 (MOL)25–66 (SGZ)48–77 (RAD)
N/ACD68 aggregates in the dorsal hippocampusNormalYesOne-way ANOVA1.0–1.7 (MOL)2.4–3.3 (SGZ)1.1–1.4 (RAD)1.4–2.6 (MOL)2.6–3.2 (SGZ)1.1–1.8 (RAD)1.3–2.4 (MOL)1.6–2.9 (SGZ)1.1–2.1 (RAD)
N/ACD68 aggregates in the ventral hippocampusNormal (MOL, SGZ)Non-normal (RAD)Yes (MOL, SGZ)No (RAD)One-way ANOVA (MOL, SGZ)Kruskal–Wallis (RAD)0.73–1.2 (MOL)2.7–3.9 (SGZ)1.0–1.7 (RAD)0.89–1.7 (MOL)2.8–3.6 (SGZ)1.2–1.8 (RAD)0.85–2.1 (MOL)3.5–4.3 (SGZ)1.0–2.1 (RAD)
7BGFAP density in the mPFCNormalYesOne-way ANOVA14,284–19,63715,287–21,32411,541–21,324
7CGFAP domain area in the mPFCNormalYesOne-way ANOVA672–894404–818558–876
8BS100 density in the mPFCNormalYesOne-way ANOVA37,563–42,40834,360–41,97233,026–44,822
8CS100 cell body area in the mPFCNormalYesOne-way ANOVA57–7554–6559–76
9BIba1 density in the mPFCNormalYesOne-way ANOVA16,458–20,88517,605–19,47614,107–22,088
9CIba1 cell body area in the mPFCNormalYesOne-way ANOVA49–5952–6153–61
N/AIba1 processes in the mPFCNormalYesOne-way ANOVA4.27–4.974.55–5.113.99–5.13
10BCD68 percent area in the mPFCNormalYesOne-way ANOVA31–4228–3931–53
N/ACD68 aggregates in the mPFCNormalYesOne-way ANOVA1.9–3.02.0–3.21.5–2.6
11BGFAP density in the DLSNormalYesOne-way ANOVA4,576–9,9992,227–10,6003,141–13,608
11CGFAP domain area in the DLSNormalYesOne-way ANOVA894.1–1,167893.7–1,281731.1–1,238
11EGFAP density in the DMSNormalYesOne-way ANOVA5,431–12,0164,384–13,1344,747–15,096
11FGFAP domain area in the DMSNormalYesOne-way ANOVA794.6–1,085791.2–1,137623.3–1,144
12BS100 density in the DLSNormalYesOne-way ANOVA14,376–20,39415,624–24,3498,112–18,553
12CS100 morphology in the DLSNormalYesOne-way ANOVA39.37–46.0341.13–46.3539.71–46.62
12ES100 density in the DMSNormalYesOne-way ANOVA21,978–29,55420,744–29,42612,672–23,759
12FS100 morphology in the DMSNormalYesOne-way ANOVA42.78–50.8840.93–49.138.35–47.89
13BIba1 density in the DLSNon-normalNoKruskal–Wallis8,376–13,6338,812–11,5707,593–9,335
13CIba1 cell body area in the DLSNormalYesOne-way ANOVA47.11–52.5546.7–53.6644.12–49.94
N/AIba1 processes in the DLSNormalYesOne-way ANOVA5.92–7.525.89–7.235.80–6.97
13EIba1 density in the DMSNon-normalNoKruskal–Wallis7,618–13,2778,374–10,9706,749–9,419
13FIba1 cell body area in the DMSNormalYesOne-way ANOVA48.51–55.5951.05–57.8145.53–51.25
N/AIba1 processes in the DMSNormalYesOne-way ANOVA5.25–5.855.97–7.454.75–6.16
14BCD68 percent area in the DLSNon-normalNoKruskal–Wallis62.06-83.8774.36-80.2459.26-84.94
14DCD68 percent area in the DMSNon-normalNoKruskal–Wallis61.11-82.6275.6-79.0252.09-84.29
N/ACD68 aggregates in the DLSNon-normalNoKruskal–Wallis2.43-4.673.21-4.112.1-3.73
N/ACD68 aggregates in the DMSNormalYesOne-way ANOVA1.84-3.322.14-3.861.77-2.95

  • hGC, Horizontal glial cell; rGC, radial glial cell.